NICE (NICE) Stock Forecast, Price Target & Predictions
NICE Stock Forecast
NICE stock forecast is as follows: an average price target of $245.00 (represents a 39.19% upside from NICE’s last price of $176.02) and a rating consensus of 'Buy', based on 9 wall street analysts offering a 1-year stock forecast.
NICE Price Target
The average price target for NICE (NICE) is $245.00 based on 1-year price targets from 9 Wall Street analysts in the past 3 months, with a price target range of $260.00 to $225.00. This represents a potential 39.19% upside from NICE's last price of $176.02.
NICE Analyst Ratings
According to 9 Wall Street analysts, NICE's rating consensus is 'Buy'. The analyst rating breakdown for NICE stock is 0 'Strong Buy' (0.00%), 9 'Buy' (100.00%), 0 'Hold' (0.00%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).
NICE Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| Nov 15, 2024 | Gil Luria | D.A. Davidson | $225.00 | $182.19 | 23.50% | 27.83% |
| Aug 16, 2024 | Daniel Ives | Wedbush | $250.00 | $174.37 | 43.37% | 42.03% |
| Aug 16, 2024 | Rishi Jaluria | RBC Capital | $260.00 | $174.37 | 49.11% | 47.71% |
| Jun 12, 2024 | James Fish | Piper Sandler | $238.00 | $174.94 | 36.05% | 35.21% |
| Jun 12, 2024 | Catharine Trebnick | Rosenblatt Securities | $225.00 | $174.94 | 28.62% | 27.83% |
| Jun 12, 2024 | Rishi Jaluria | RBC Capital | $230.00 | $175.42 | 31.11% | 30.67% |
| May 17, 2024 | Tavy Rosner | Barclays | $320.00 | $193.55 | 65.33% | 81.80% |
| May 17, 2024 | Siti Panigrahi | Mizuho Securities | $280.00 | $198.60 | 40.99% | 59.07% |
| May 17, 2024 | Rishi Jaluria | RBC Capital | $265.00 | $198.60 | 33.43% | 50.55% |
| May 16, 2024 | Nawar Cristini | Morgan Stanley | $290.00 | $198.60 | 46.02% | 64.75% |
| May 16, 2024 | Rishi Jaluria | RBC Capital | $285.00 | $198.60 | 43.50% | 61.91% |
| May 16, 2024 | Samad Samana | Jefferies | $230.00 | $198.60 | 15.81% | 30.67% |
| Apr 23, 2024 | Catharine Trebnick | Rosenblatt Securities | $285.00 | $224.42 | 26.99% | 61.91% |
| Apr 09, 2024 | James Fish | Piper Sandler | $269.00 | $242.05 | 11.13% | 52.82% |
| Mar 12, 2024 | Gil Luria | D.A. Davidson | $300.00 | $241.04 | 24.46% | 70.44% |
| Feb 23, 2024 | Patrick Walravens | JMP Securities | $343.00 | $238.75 | 43.67% | 94.86% |
| Oct 05, 2023 | Rishi Jaluria | RBC Capital | $238.00 | $167.09 | 42.44% | 35.21% |
| Oct 05, 2023 | Timothy Horan | Oppenheimer | $225.00 | $167.09 | 34.66% | 27.83% |
| Nov 11, 2022 | Citigroup | $260.00 | $201.62 | 28.96% | 47.71% |
The latest NICE stock forecast, released on Nov 15, 2024 by Gil Luria from D.A. Davidson, set a price target of $225.00, which represents a 23.50% increase from the stock price at the time of the forecast ($182.19), and a 27.83% increase from NICE last price ($176.02).
NICE Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | - | 1 | 16 |
| Avg Price Target | - | $225.00 | $268.44 |
| Last Closing Price | $176.02 | $176.02 | $176.02 |
| Upside/Downside | -100.00% | 27.83% | 52.51% |
In the current month, the average price target of NICE stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to NICE's last price of $176.02. This month's average price target is down -100.00% compared to last quarter, and down -100.00% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| Nov 15, 2024 | Citigroup | Buy | Buy | Hold |
| Oct 03, 2024 | Rosenblatt Securities | Underperform | Underperform | Hold |
| Oct 03, 2024 | Wedbush | Buy | Buy | Hold |
| Aug 16, 2024 | Wedbush | Outperform | Outperform | Hold |
| Aug 16, 2024 | RBC Capital | Outperform | Outperform | Hold |
| Jul 25, 2024 | Wedbush | Buy | Buy | Hold |
| Jul 25, 2024 | Rosenblatt Securities | Underperform | Underperform | Hold |
| Jun 12, 2024 | Wedbush | Market Outperform | Market Outperform | Hold |
| Jun 12, 2024 | Rosenblatt Securities | Underperform | Underperform | Hold |
| Jun 12, 2024 | Citigroup | Buy | Buy | Hold |
| Jun 12, 2024 | Piper Sandler | Overweight | Overweight | Hold |
| Jun 12, 2024 | RBC Capital | Outperform | Outperform | Hold |
| May 17, 2024 | Barclays | Overweight | Overweight | Hold |
| May 17, 2024 | Bank of America Securities | Buy | Buy | Hold |
| May 16, 2024 | Morgan Stanley | Overweight | Overweight | Hold |
| May 16, 2024 | RBC Capital | Outperform | Outperform | Hold |
| May 16, 2024 | Jefferies | Buy | Buy | Hold |
| May 15, 2024 | Rosenblatt Securities | Underperform | Underperform | Hold |
| May 15, 2024 | Wedbush | Market Outperform | Market Outperform | Hold |
| Apr 23, 2024 | Wedbush | Market Outperform | Market Outperform | Hold |
| Apr 23, 2024 | Rosenblatt Securities | Underperform | Underperform | Hold |
| Apr 09, 2024 | Piper Sandler | Overweight | Overweight | Hold |
| Mar 13, 2024 | Wedbush | Market Outperform | Market Outperform | Hold |
| Mar 13, 2024 | RBC Capital | Underperform | Underperform | Hold |
| Feb 23, 2024 | Wedbush | Outperform | Outperform | Hold |
| Feb 23, 2024 | RBC Capital | Outperform | Outperform | Hold |
| Feb 21, 2024 | Northland Securities | Market Outperform | Market Outperform | Hold |
| Feb 21, 2024 | JMP Securities | Underperform | Underperform | Hold |
| Dec 18, 2023 | Oppenheimer | Underperform | Underperform | Hold |
| Dec 18, 2023 | RBC Capital | Market Outperform | Market Outperform | Hold |
| Oct 16, 2023 | Morgan Stanley | Equal-Weight | Overweight | Upgrade |
| Oct 05, 2023 | RBC Capital | Outperform | Outperform | Hold |
| Oct 05, 2023 | Oppenheimer | Outperform | Outperform | Hold |
| May 12, 2023 | Wedbush | Outperform | Outperform | Hold |
| Nov 11, 2022 | Citigroup | Buy | Buy | Hold |
| Jul 26, 2022 | Barclays | Overweight | Overweight | Hold |
| Feb 22, 2022 | Morgan Stanley | Equal-Weight | Equal-Weight | Hold |
| Feb 18, 2022 | Jefferies | Buy | Buy | Hold |
| Nov 22, 2021 | RBC Capital | Outperform | Outperform | Hold |
NICE's last stock rating was published by Citigroup on Nov 15, 2024. The company gave NICE a "Buy" rating, the same as its previous rate.
NICE Financial Forecast
NICE Revenue Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $571.86M | $568.56M | $554.72M | $530.58M | $527.43M | $515.47M | $490.40M | $456.03M | $455.02M | $434.58M | $409.83M | $393.18M | $410.43M | $430.21M | $386.26M |
| Avg Forecast | $867.40M | $827.86M | $801.21M | $791.22M | $790.69M | $757.71M | $734.22M | $727.14M | $715.26M | $683.55M | $664.10M | $655.41M | $616.83M | $595.00M | $579.30M | $563.97M | $569.69M | $548.82M | $525.01M | $510.92M | $496.36M | $465.73M | $450.30M | $451.08M | $433.34M | $408.04M | $392.15M | $410.10M | $429.50M | $385.17M |
| High Forecast | $885.56M | $845.20M | $817.99M | $807.79M | $807.25M | $773.57M | $749.59M | $748.80M | $718.56M | $697.86M | $664.10M | $655.41M | $620.24M | $596.81M | $591.43M | $575.79M | $581.62M | $548.82M | $525.01M | $510.92M | $496.36M | $465.73M | $450.30M | $451.08M | $433.34M | $408.04M | $392.15M | $410.10M | $429.50M | $385.17M |
| Low Forecast | $853.61M | $814.70M | $788.47M | $778.64M | $778.13M | $745.66M | $722.55M | $715.57M | $711.24M | $672.68M | $664.10M | $655.41M | $612.43M | $589.81M | $570.09M | $555.01M | $560.63M | $548.82M | $525.01M | $510.92M | $496.36M | $465.73M | $450.30M | $451.08M | $433.34M | $408.04M | $392.15M | $410.10M | $429.50M | $385.17M |
| # Analysts | 7 | 4 | 4 | 7 | 5 | 3 | 3 | 9 | 10 | 5 | 4 | 5 | 7 | 11 | 5 | 10 | 6 | 4 | 4 | 7 | 5 | 5 | 10 | 7 | 5 | 9 | 9 | 9 | 8 | 8 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.01% | 1.00% | 1.01% | 1.01% | 1.03% | 1.04% | 1.05% | 1.01% | 1.01% | 1.00% | 1.00% | 1.00% | 1.00% | 1.00% | 1.00% |
NICE's average Quarter revenue forecast for Jun 23 based on 5 analysts is $579.30M, with a low forecast of $570.09M, and a high forecast of $591.43M. NICE's average Quarter revenue forecast represents a 1.30% increase compared to the company's last Quarter revenue of $571.86M (Mar 23).
NICE EBITDA Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 7 | 4 | 4 | 7 | 5 | 3 | 3 | 9 | 10 | 5 | 4 | 5 | 7 | 11 | 5 | 10 | 6 | 4 | 4 | 7 | 5 | 5 | 10 | 7 | 5 | 9 | 9 | 9 | 8 | 8 |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $135.35M | $135.29M | $132.89M | $126.89M | $116.64M | $104.72M | $106.79M | $101.21M | $108.01M | $109.36M | $106.52M | $102.34M | $101.31M | $121.52M | $99.88M |
| Avg Forecast | $217.83M | $207.90M | $201.20M | $198.70M | $198.56M | $190.28M | $184.38M | $182.60M | $179.62M | $171.66M | $166.77M | $134.27M | $154.90M | $149.42M | $145.48M | $122.06M | $129.37M | $136.79M | $130.85M | $110.97M | $123.71M | $116.08M | $112.23M | $104.38M | $108.00M | $101.70M | $97.74M | $99.78M | $107.05M | $96.00M |
| High Forecast | $222.39M | $212.25M | $205.42M | $202.86M | $202.72M | $194.26M | $188.24M | $188.04M | $180.45M | $175.25M | $166.77M | $161.12M | $155.76M | $149.87M | $148.52M | $146.48M | $155.24M | $136.79M | $130.85M | $133.16M | $123.71M | $116.08M | $112.23M | $125.26M | $108.00M | $101.70M | $97.74M | $119.73M | $107.05M | $96.00M |
| Low Forecast | $214.36M | $204.59M | $198.01M | $195.54M | $195.41M | $187.25M | $181.45M | $179.70M | $178.61M | $168.93M | $166.77M | $107.42M | $153.80M | $148.12M | $143.16M | $97.65M | $103.50M | $136.79M | $130.85M | $88.77M | $123.71M | $116.08M | $112.23M | $83.51M | $108.00M | $101.70M | $97.74M | $79.82M | $107.05M | $96.00M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.11% | 1.05% | 0.97% | 0.97% | 1.05% | 0.85% | 0.92% | 0.90% | 1.03% | 1.01% | 1.05% | 1.05% | 1.02% | 1.14% | 1.04% |
5 analysts predict NICE's average Quarter EBITDA for Jun 23 to be $145.48M, with a high of $148.52M and a low of $143.16M. This is 7.48% upper than NICE's previous annual EBITDA (Mar 23) of $135.35M.
NICE Net Income Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 7 | 4 | 4 | 7 | 5 | 3 | 3 | 9 | 10 | 5 | 4 | 5 | 7 | 11 | 5 | 10 | 6 | 4 | 4 | 7 | 5 | 5 | 10 | 7 | 5 | 9 | 9 | 9 | 8 | 8 |
| Net Income | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $76.94M | $71.19M | $71.25M | $65.57M | $57.94M | $51.16M | $47.08M | $44.78M | $52.21M | $54.92M | $50.77M | $44.79M | $46.20M | $61.74M | $45.04M |
| Avg Forecast | $238.13M | $225.07M | $211.25M | $206.54M | $212.81M | $203.53M | $192.53M | $188.42M | $191.16M | $173.56M | $167.15M | $66.42M | $146.57M | $139.24M | $133.22M | $60.38M | $63.20M | $122.91M | $118.15M | $54.89M | $112.41M | $104.29M | $99.30M | $50.46M | $102.43M | $91.59M | $87.23M | $45.50M | $100.52M | $84.59M |
| High Forecast | $244.61M | $231.20M | $217.00M | $212.16M | $218.60M | $209.07M | $197.77M | $194.27M | $194.39M | $178.29M | $167.15M | $79.70M | $151.11M | $141.18M | $136.85M | $72.46M | $75.84M | $122.91M | $118.15M | $65.87M | $118.49M | $104.29M | $99.30M | $60.55M | $102.43M | $91.59M | $87.23M | $54.60M | $100.52M | $84.59M |
| Low Forecast | $233.20M | $220.42M | $206.89M | $202.27M | $208.41M | $199.32M | $188.55M | $180.63M | $188.58M | $169.98M | $167.15M | $53.13M | $142.68M | $136.00M | $130.47M | $48.30M | $50.56M | $122.91M | $118.15M | $43.91M | $106.33M | $104.29M | $99.30M | $40.37M | $102.43M | $91.59M | $87.23M | $36.40M | $100.52M | $84.59M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.27% | 1.13% | 0.58% | 0.56% | 1.06% | 0.46% | 0.45% | 0.45% | 1.03% | 0.54% | 0.55% | 0.51% | 1.02% | 0.61% | 0.53% |
NICE's average Quarter net income forecast for Jun 23 is $133.22M, with a range of $130.47M to $136.85M. NICE's average Quarter net income forecast represents a 73.15% increase compared to the company's last Quarter net income of $76.94M (Mar 23).
NICE SG&A Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 7 | 4 | 4 | 7 | 5 | 3 | 3 | 9 | 10 | 5 | 4 | 5 | 7 | 11 | 5 | 10 | 6 | 4 | 4 | 7 | 5 | 5 | 10 | 7 | 5 | 9 | 9 | 9 | 8 | 8 |
| SG&A | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $213.66M | $217.79M | $219.60M | $207.49M | $211.49M | $209.83M | $190.91M | $179.33M | $181.53M | $157.53M | $142.81M | $137.90M | $148.93M | $153.06M | $138.58M |
| Avg Forecast | $323.34M | $308.61M | $298.67M | $294.95M | $294.75M | $282.45M | $273.70M | $271.06M | $266.63M | $254.81M | $247.56M | $242.43M | $229.94M | $221.80M | $215.95M | $220.39M | $259.22M | $203.94M | $195.09M | $200.35M | $184.45M | $173.07M | $167.33M | $175.44M | $161.03M | $151.63M | $145.72M | $146.67M | $159.60M | $143.13M |
| High Forecast | $330.12M | $315.07M | $304.92M | $301.12M | $300.92M | $288.37M | $279.43M | $279.13M | $267.86M | $260.15M | $247.56M | $290.91M | $231.21M | $222.48M | $220.47M | $264.47M | $311.06M | $203.94M | $195.09M | $240.43M | $184.45M | $173.07M | $167.33M | $210.53M | $161.03M | $151.63M | $145.72M | $176.01M | $159.60M | $143.13M |
| Low Forecast | $318.20M | $303.70M | $293.92M | $290.26M | $290.07M | $277.96M | $269.35M | $266.75M | $265.13M | $250.76M | $247.56M | $193.94M | $228.30M | $219.87M | $212.52M | $176.31M | $207.38M | $203.94M | $195.09M | $160.28M | $184.45M | $173.07M | $167.33M | $140.35M | $161.03M | $151.63M | $145.72M | $117.34M | $159.60M | $143.13M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.97% | 0.84% | 1.08% | 1.06% | 1.06% | 1.14% | 1.10% | 1.07% | 1.03% | 0.98% | 0.94% | 0.95% | 1.02% | 0.96% | 0.97% |
NICE's average Quarter SG&A projection for Jun 23 is $215.95M, based on 5 Wall Street analysts, with a range of $212.52M to $220.47M. The forecast indicates a 1.07% rise compared to NICE last annual SG&A of $213.66M (Mar 23).
NICE EPS Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 7 | 4 | 4 | 7 | 5 | 3 | 3 | 9 | 10 | 5 | 4 | 5 | 7 | 11 | 5 | 10 | 6 | 4 | 4 | 7 | 5 | 5 | 10 | 7 | 5 | 9 | 9 | 9 | 8 | 8 |
| EPS | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $1.20 | $1.11 | $1.12 | $1.03 | $0.91 | $0.81 | $0.75 | $0.70 | $0.83 | $0.87 | $0.81 | $0.71 | $0.74 | $0.99 | $0.72 |
| Avg Forecast | $3.67 | $3.47 | $3.26 | $3.19 | $3.28 | $3.14 | $2.97 | $2.91 | $2.95 | $2.68 | $2.58 | $2.45 | $2.26 | $2.15 | $2.05 | $1.98 | $1.93 | $1.87 | $1.79 | $1.71 | $1.71 | $1.58 | $1.51 | $1.50 | $1.56 | $1.39 | $1.32 | $1.32 | $1.53 | $1.28 |
| High Forecast | $3.77 | $3.57 | $3.35 | $3.27 | $3.37 | $3.22 | $3.05 | $3.00 | $3.00 | $2.75 | $2.58 | $2.45 | $2.33 | $2.18 | $2.11 | $2.03 | $1.94 | $1.87 | $1.79 | $1.71 | $1.80 | $1.58 | $1.51 | $1.50 | $1.56 | $1.39 | $1.32 | $1.32 | $1.53 | $1.28 |
| Low Forecast | $3.60 | $3.40 | $3.19 | $3.12 | $3.21 | $3.07 | $2.91 | $2.79 | $2.91 | $2.62 | $2.58 | $2.45 | $2.20 | $2.10 | $2.01 | $1.93 | $1.92 | $1.87 | $1.79 | $1.71 | $1.61 | $1.58 | $1.51 | $1.50 | $1.56 | $1.39 | $1.32 | $1.32 | $1.53 | $1.28 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.61% | 0.58% | 0.60% | 0.57% | 0.53% | 0.47% | 0.47% | 0.46% | 0.55% | 0.56% | 0.58% | 0.54% | 0.56% | 0.65% | 0.56% |
According to 5 Wall Street analysts, NICE's projected average Quarter EPS for Jun 23 is $2.05, with a low estimate of $2.01 and a high estimate of $2.11. This represents a 71.23% increase compared to NICE previous annual EPS of $1.20 (Mar 23).